Cardiovascular endocrinology is an interdisciplinary field that explores the intricate connections between the endocrine system and cardiovascular health. The endocrine system, consisting of glands that produce hormones, plays a crucial role in regulating various physiological processes, including those related to the cardiovascular system. Hormones such as insulin, cortisol, and thyroid hormones influence blood pressure, heart rate, and metabolism. Disorders of the endocrine system, such as diabetes and thyroid dysfunction, can have profound effects on cardiovascular health and increase the risk of developing heart diseases. Cardiovascular endocrinologists focus on understanding these complex interactions, investigating how hormonal imbalances contribute to atherosclerosis, hypertension, and other cardiovascular conditions. The field aims to identify novel therapeutic targets and interventions that address both endocrine and cardiovascular components, promoting holistic approaches to the prevention and management of cardiovascular diseases.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation